Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell death inhibitors are molecules or proteins that prevent or delay programmed cell death (apoptosis). Key families include Inhibitor of Apoptosis Proteins (IAPs) and Bcl-2 family proteins. IAPs inhibit caspases, while anti-apoptotic Bcl-2 members block mitochondrial cytochrome c release. Viral inhibitors like crmA also target caspases. These inhibitors are dysregulated in diseases like cancer, making them therapeutic targets.
Small molecule antagonists targeting IAPs and Bcl-2 proteins; BH3 mimetics disrupt interactions between pro-survival/pro-death Bcl–2 family members; SMAC mimetics antagonize IAP function
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell Death Inhibitor.